Direct Comparative Effectiveness Among 3 Anti–Tumor Necrosis Factor Biologics in a Real-Life Cohort of Patients With Rheumatoid Arthritis

OBJECTIVE: This study aimed to compare the clinical response at 36 months and evaluate the adverse events in a cohort of patients with rheumatoid arthritis treated with etanercept, infliximab, or adalimumab. METHODS: An observational retrospective cohort study was performed. Patients older than 18 y...

Descripción completa

Detalles Bibliográficos
Autores principales: Santos-Moreno, Pedro, Sánchez, Guillermo, Gómez, Danny, Bello-Gualtero, Juan, Castro, Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4927323/
https://www.ncbi.nlm.nih.gov/pubmed/26886438
http://dx.doi.org/10.1097/RHU.0000000000000358

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4927323/
https://www.ncbi.nlm.nih.gov/pubmed/26886438
http://dx.doi.org/10.1097/RHU.0000000000000358

Ejemplares similares